Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference66 articles.
1. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.;Soriano;Lancet Respir Med,2017
2. The cardiopulmonary continuum systemic inflammation as ‘common soil’ of heart and lung disease.;Ukena;Int J Cardiol,2010
3. Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services.;Hawkins;Eur Heart J,2013
4. Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: evidence from SUSPIRIUM, a multicentre Italian survey.;Griffo;Eur J Prev Cardiol,2017
5. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes.;Young;Eur Respir J,2007
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An overview of the efficacy and safety of β 2 -adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease;Expert Opinion on Drug Safety;2024-06-02
2. Chronic Obstructive Pulmonary Disease, Part 5: Clinical Pearls for Comorbid COPD;The Senior Care Pharmacist;2023-10-01
3. The Coexistence of Chronic Obstructive Pulmonary Disease and Heart Failure;Cureus;2021-08-23
4. Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease;ESC Heart Failure;2021-06-29
5. Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF;European Journal of Heart Failure;2021-01-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3